Stock screener

BLCO

Conviction 42HealthcareScan · Thu, Sep 24, 2026

Bausch & Lomb Corp (BLCO) closed at $16.82 (-1.35%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 44, RS Rating 67, -9.6% from its 52-week high, +1.5% year to date. Sector: Healthcare · OPHTHALMIC GOODS.

BLCO$16.82-1.35%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 358.44K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Bausch & Lomb CorpOPHTHALMIC GOODSwww.bausch.com ↗
Price16.82
Change-1.35%
Gap+0.15%
Rel volume0.36×
Avg volume395.41K
Avg $ vol6.88M
SMA 2017.38
SMA 5016.99
SMA 20016.63
Price vs 50-0.98%
Price vs 200+1.12%
MA stackmixed
50/200 cross—
Supertrenddown · 18.22
RSI (14)44
MACD hist-0.10
MACD cross—
Stoch %K / %D14 / 26
ADX (14)13
+DI / −DI17 / 20
RSI divergence—
MACD divergence—
ATR %2.76%
ADR %2.64%
52w high18.60
52w low14.32
From 52w high-9.57%
Above 52w low+17.46%
New 52w highNo
SqueezeOff
Bollinger width9.88%
%B0.17
Donchian pos11.80%
Donchian high18.47
Donchian low16.60
AVWAP (52w high)16.41
vs AVWAP high+2.47%
AVWAP (52w low)16.38
vs AVWAP low+2.70%
OBV trendFlat
Chaikin MF (20)-0.03
Today vs 20d0.36×
Avg vol (14d)358.44K
Avg vol (20d)395.41K
Avg $ vol (20d)6.88M
Market cap6.01B
RS Rating67 / 99
RS 3m (vs SPY)+1.23%
RS 6m (vs SPY)-11.82%
RS line new highNo
Trend template4/8
Technical rank56.1
1 week+0.30%
1 month-2.49%
3 months+5.72%
6 months+4.99%
1 year+11.54%
YTD+1.45%
P/E-16.69
P/B0.94
P/S1.18
P/FCF-91.02
EPS-1.02
Div yield—
ROE-5.65%
ROA-2.60%
Debt/Eq0.80
Current1.55
EV/EBITDA20.07
Gross margin—
Net margin-7.06%
Rev growth6.47%
EPS growth-13.56%
Price target20.22
Target upside20.21%
Analyst ratingBuy
Institutional10.84%
Ent. value10.72B
Revenue1.39B
Net income-14M
Gross profit—
Free cash flow-66M
IndustryOPHTHALMIC GOODS
ExchangeNYSE
Shares out357.04M
Employees13K
ListedFri, May 6, 2022
Free float43.32M
Float %12.2%
Short interest3.41M
Days to cover7.9d
Short volume64.6%
Squeeze score57 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.16 vs $0.16
Last surprise0.0% beat
Setup gradeD
Conviction42 / 100
Pattern quality—
Tech rank56.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance18.34
Support16.22
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BLCO

All disclosures →
No recent disclosed trades by Congress in BLCO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BLCO · open-market 3 sells

InsiderSideShares
Trebbi Barbara
Director · Common Shares, No Par Value · 2026-08-12
Grant11.78K
Chersi Robert J
Director · Common Shares, No Par Value · 2026-08-12
Grant11.78K
PAUL LAURENCE E
Director · Common Shares, No Par Value · 2026-08-12
Grant11.78K
Munsch Frederick
SVP, Controller and CAO · Common Shares, No Par Value · 2026-08-10
Sell52.9K
VON ESCHENBACH ANDREW C.
Director · Common Shares, No Par Value · 2026-08-07
Sell6.06K
VON ESCHENBACH ANDREW C.
Director · Common Shares, No Par Value · 2026-08-06
Sell12.5K
Munsch Frederick
SVP, Controller and CAO · Common Shares, No Par Value · 2026-08-05
Grant9.09K
Stewart Andrew J.
President, GPIC · Common Shares, No Par Value · 2026-08-05
Grant16.78K
SAUNDERS BRENT L
Chairman of the Board and CEO · Common Shares, No Par Value · 2026-08-05
Tax4.23K
Bailey A Robert D
EVP & Chief Legal Officer · Common Shares, No Par Value · 2026-08-05
Grant33.56K

SEC filings

EDGAR filings in BLCO · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.